The purpose of this resolution is to highlight the importance of Charcot-Marie-Tooth disease (CMT) and to advocate for increased funding for research on this condition at the National Institute of Neurological Disorders and Stroke, which is part of the National Institutes of Health. The resolution aims to raise awareness about CMT and the need for more resources to understand and address this disease. Key provisions of the resolution include a recognition of the significant impact of CMT on individuals, with an estimated 126,000 people affected in the United States and millions worldwide.